CapsoVision (CV) Net Cash Flow (2024 - 2025)
CapsoVision (CV) posted Net Cash Flow of -$7.7 million for Q4 2025, down 145.96% sequentially from $16.7 million in Q3 2025, and down 1829.4% YoY from $444027.6 in Q4 2024.
CapsoVision (CV) Net Cash Flow (2024 - 2025) Analysis & Trends
CapsoVision has reported Net Cash Flow for 2 years, with the latest figure at -$7.7 million in Q4 2025.
- Quarterly Net Cash Flow fell 1829.4% year-over-year to -$7.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.6 million (changed N/A YoY) and the FY2025 annual result came in at $650000.0, up 112.57% from the prior year.
- Net Cash Flow eased to -$7.7 million in Q4 2025 per CV's latest filing, from $16.7 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $16.7 million in Q3 2025 and troughed at -$7.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.90 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 126.12 Bn | 122.64 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 118.45 Bn | 109.23 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 73.30 Bn | 72.77 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 51.60 Bn | 47.35 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 34.52 Bn | 32.57 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 33.71 Bn | 31.60 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.14 Bn | 22.82 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.13 Bn | 22.65 Bn | 684.20 Mn | 45.10 Mn |
| 10 | CapsoVision | 298.63 Mn | 289.55 Mn | 1.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.68 Mn |
| Dec 31, 2025 | -7.68 Mn |
| Sep 30, 2025 | 16.71 Mn |
| Sep 30, 2025 | 16.71 Mn |
| Dec 31, 2024 | -398,000.00 |
| Dec 31, 2024 | -398,000.00 |
| Sep 30, 2024 | 2.94 Mn |
| Sep 30, 2024 | 2.94 Mn |